FDA Inspection 1326618 — Matthias H. Kapturczak, M.D., Ph.D
The FDA completed an inspection of Matthias H. Kapturczak, M.D., Ph.D on Jul 10, 2026 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 10, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional Details
Clinical Investigator (CI)